东诚药业：累计回购约403万股

Group 1 - Dongcheng Pharmaceutical announced a share buyback plan, repurchasing approximately 4.03 million shares, which accounts for 0.49% of the total share capital [1] - The buyback was conducted through a centralized bidding method, with a total expenditure of approximately RMB 57.17 million [1] - The highest transaction price during the buyback was RMB 14.74 per share, while the lowest was RMB 13.87 per share [1] Group 2 - The news highlights a significant market reaction to external events, particularly related to Trump, which caused gold prices to drop sharply [1] - Over the previous two weeks, gold prices had surged by 21%, indicating high volatility in the market [1] - Various institutions have provided their outlooks on the future market trends following these events [1]